The usage of magnetic nanoparticles (MNPs), particularly iron oxide-based systems such as magnetite (Fe3O4) and maghemite (γ-Fe2O3), has significantly advanced the field of theranostics. These nanoparticles unite therapeutic and diagnostic capabilities due to their favorable magnetic properties and surface engineering potential. However, the path from synthesis to clinical application poses substantial challenges, including optimization of structure–property–function relationships, biocompatibility issues, and effective surface functionalization. Various synthesis methods, such as co-precipitation and thermal decomposition, aim to achieve specific nanoparticle characteristics, although they encounter obstacles related to scalability and reproducibility. Furthermore, characterizing these systems through structural, microstructural and spectroscopic techniques is vital to determine their functional efficacy and ensure their safe biomedical usage. This review comprehensively examines recent advancements and identifies existing challenges in the clinical translation of MNPs, highlighting the need for refined methods and standardized protocols to effectively exploit their theranostic potential. It outlines future directions, emphasizing the importance of green synthesis and robust characterization frameworks to enhance the integration of MNPs in personalized medicine.
Colombo et al. (2026) studied this question.